Studies from University of Pisa Reveal New Findings on Lymphoma HispanicBusiness.com Among different possible chemotherapeutic approaches, purine analogs, alone or in association with Rituximab, seem to be a valid therapeutic choice. Fifty SMZL patients were treated with Cladribine +/- anti-CD20 monoclonal antibody. Forty-seven of 50 ... |
